Experimental Study of Risk Information Amount and Location in Direct-to-Consumer Print Ads

OMB 0910-0861

OMB 0910-0861

This information collection request collects information from an adult sample of individuals who self-identify as having rheumatoid arthritis or overactive bladder regarding their perceptions of the important safety information and brief summary in direct-to-consumer prescription drug print advertising. Additionally, we will collect eye-tracking data to observe participants’ gaze maps while reading the information. Using an in-person interview methodology, we plan to conduct two 60-minute pilots with a total of 40 adults and two 60-minute studies with a total of 400 adults.

The latest form for Experimental Study of Risk Information Amount and Location in Direct-to-Consumer Print Ads expires 2020-09-30 and can be found here.

OMB Details

Pilot Screener

Federal Enterprise Architecture: Health - Consumer Health and Safety


© 2021 OMB.report | Privacy Policy